203 related articles for article (PubMed ID: 21108564)
21. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
22. [Genetic polymorphism of the hepatic metabolism of drugs].
Larrey D; Pessayre D; Benhamou JP
Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
[No Abstract] [Full Text] [Related]
23. Modulation of hepatic and renal drug metabolizing enzyme activities in rats by subchronic administration of farnesol.
Horn TL; Long L; Cwik MJ; Morrissey RL; Kapetanovic IM; McCormick DL
Chem Biol Interact; 2005 Apr; 152(2-3):79-99. PubMed ID: 15840382
[TBL] [Abstract][Full Text] [Related]
24. Effect of fasting on metabolite-mediated hepatotoxicity in the rat.
Pessayre D; Dolder A; Artigou JY; Wandscheer JC; Descatoire V; Degott C; Benhamou JP
Gastroenterology; 1979 Aug; 77(2):264-71. PubMed ID: 109346
[TBL] [Abstract][Full Text] [Related]
25. Reduction of toxic metabolite formation of acetaminophen.
Hazai E; Vereczkey L; Monostory K
Biochem Biophys Res Commun; 2002 Mar; 291(4):1089-94. PubMed ID: 11866476
[TBL] [Abstract][Full Text] [Related]
26. Regional differences in peroxidatic activation of paracetamol (acetaminophen) mediated by cytochrome P450 and prostaglandin endoperoxide synthetase in rabbit kidney.
Mohandas J; Duggin GG; Horvath JS; Tiller DJ
Res Commun Chem Pathol Pharmacol; 1981 Oct; 34(1):69-80. PubMed ID: 6797006
[TBL] [Abstract][Full Text] [Related]
27. The small intestine as a xenobiotic-metabolizing organ.
Kaminsky LS; Zhang QY
Drug Metab Dispos; 2003 Dec; 31(12):1520-5. PubMed ID: 14625348
[No Abstract] [Full Text] [Related]
28. Fatal liver failure after therapeutic doses of paracetamol in a patient with Duchenne muscular dystrophy and atypical pharmacogenetic profile of drug-metabolizing enzymes.
Lao YE; Molden E; Kringen MK; Annexstad EJ; Saeverud HA; Jacobsen D; Hovda KE
Basic Clin Pharmacol Toxicol; 2020 Jul; 127(1):47-51. PubMed ID: 31977139
[TBL] [Abstract][Full Text] [Related]
29. [Effect of folic acid on the activity of monooxygenase system, UDP-glucuronyl- and glutathione-S-transferase in the normal and regenerating rat liver].
Bushma MI; Legon'kova LF; Lukienko PI
Vopr Med Khim; 1987; 33(4):93-5. PubMed ID: 3116769
[TBL] [Abstract][Full Text] [Related]
30. [Does the cytochrome P-450-dependent system of microsomal monooxygenases protect the body from the toxic effect of xenobiotics?].
Lutz W; Szeszko A; Stankiewicz A
Pol Tyg Lek; 1988 Jun; 43(25):795-8. PubMed ID: 3149404
[No Abstract] [Full Text] [Related]
31. Arjunolic acid, a triterpenoid saponin, prevents acetaminophen (APAP)-induced liver and hepatocyte injury via the inhibition of APAP bioactivation and JNK-mediated mitochondrial protection.
Ghosh J; Das J; Manna P; Sil PC
Free Radic Biol Med; 2010 Feb; 48(4):535-53. PubMed ID: 19969075
[TBL] [Abstract][Full Text] [Related]
32. Cancer and molecular biomarkers of phase 2.
Dalhoff K; Buus Jensen K; Enghusen Poulsen H
Methods Enzymol; 2005; 400():618-27. PubMed ID: 16399374
[TBL] [Abstract][Full Text] [Related]
33. [The role of paracetamol in transition reactions of alpha-nitrogen and oxidative stress in the liver].
Polaniak R; BuĊdak RJ; Birkner E; Karbowska D; Ochocki K; Szkilnik R
Pol Merkur Lekarski; 2012 Dec; 33(198):346-8. PubMed ID: 23437706
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA regulation of the major drug-metabolizing enzymes and related transcription factors.
Dluzen DF; Lazarus P
Drug Metab Rev; 2015 Aug; 47(3):320-34. PubMed ID: 26300547
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis.
Kadlubar FF; Butler MA; Kaderlik KR; Chou HC; Lang NP
Environ Health Perspect; 1992 Nov; 98():69-74. PubMed ID: 1486865
[TBL] [Abstract][Full Text] [Related]
36. The impact of genetic factors on response to anaesthetics.
Mikstacki A; Skrzypczak-Zielinska M; Tamowicz B; Zakerska-Banaszak O; Szalata M; Slomski R
Adv Med Sci; 2013; 58(1):9-14. PubMed ID: 23640947
[TBL] [Abstract][Full Text] [Related]
37. Key factors of susceptibility to anti-tuberculosis drug-induced hepatotoxicity.
Chen R; Wang J; Zhang Y; Tang S; Zhan S
Arch Toxicol; 2015 Jun; 89(6):883-97. PubMed ID: 25693865
[TBL] [Abstract][Full Text] [Related]
38. Detoxification enzymes: cellular metabolism and susceptibility to various diseases.
Silva M; Carvalho MDG
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):307-310. PubMed ID: 30133607
[No Abstract] [Full Text] [Related]
39. Ontogeny of Human Conjugating Enzymes.
Coughtrie MW
Drug Metab Lett; 2015; 9(2):99-108. PubMed ID: 26031463
[TBL] [Abstract][Full Text] [Related]
40. Genetic differences in cataract and other ocular abnormalities induced by paracetamol and naphthalene.
Shichi H; Tanaka M; Jensen NM; Nebert DW
Pharmacology; 1980; 20(5):229-41. PubMed ID: 7393992
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
